Drug Demand Reduction Workforce Credentialing
ID: 353424Type: Posted
Overview

Buyer

Bureau of International Narcotics-Law Enforcement (DOS-INL)

Award Range

$400K - $600K

Eligible Applicants

Others

Funding Category

Other

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353424
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Apr 5, 2024 12:00 AM
  4. 4
    Due Jun 4, 2024 12:00 AM
Description

The Bureau of International Narcotics-Law Enforcement is offering a federal grant opportunity titled "Drug Demand Reduction Workforce Credentialing". This cooperative agreement aims to encourage the development and dissemination of a global credential and related credentialing or certification program based on international standards for substance use professionals. The grant is open to various organizations, including U.S.-based non-profit/non-governmental organizations (NGOs), U.S.-based educational institutions, foreign-based non-profits/non-governmental organizations (NGOs), and foreign-based educational institutions. The grant has an award ceiling of $600,000 and an award floor of $400,000, with an estimated total program funding of $600,000. The deadline for applications is June 4, 2024. For more information, you can visit the opportunity in MyGrants.

Point(s) of Contact
parsonsdm@state.gov
Files
Title
Posted
FY23 INL Templates and Forms for Grants.gov.zip
4/10/2024
Similar Opportunities
Strengthening Community Resilience and Policing in Uzbekistan
Active
Bureau of International Narcotics-Law Enforcement
The Bureau of International Narcotics-Law Enforcement is offering a grant opportunity titled "Strengthening Community Resilience and Policing in Uzbekistan". This grant aims to support organizations in carrying out a project to enhance community policing practices in Uzbekistan. The project seeks to address the low public trust in security forces and the fragmented state of civil society in the country. It aims to strengthen civil society organizations' capacity for community-based advocacy and help local government actors, particularly the Ministry of Internal Affairs, develop protocols and procedures to improve transparency, responsiveness, and communication with local communities. The grant has an award ceiling of $300,000 and an award floor of $100,000, with an estimated total program funding of $300,000. The expected number of awards is two. The grant is open to U.S.-based non-profit and non-governmental organizations, U.S.-based educational institutions, foreign-based non-profits/non-governmental organizations, and foreign-based educational institutions. The deadline for submission is August 5, 2024. For more information, you can visit the [link](https://mygrants.servicenowservices.com/mygrants?id=mygrants_form&table=x_g_usd4_o_grant_funding_opportunity&sys_id=30eaceb147ea8a104f681864336d43ca&view=Default).
HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional)". This grant opportunity falls under the category of Health and is a Cooperative Agreement. The grant does not require cost sharing or matching. The purpose of this grant is to address the overdose crisis in the context of the criminal justice system, specifically focusing on justice-involved populations and criminal-legal systems. The grant aims to increase the delivery of and access to Medications for Opioid Use Disorder (MOUD) to individuals in the US justice system. It is important to note that individuals in the US justice system are disproportionately likely to have Substance Use Disorder/Opioid Use Disorder (SUD/OUD), and they are at high risk for opioid withdrawal upon incarceration and overdose post-release if they have not received MOUD while detained. The grant seeks to fund a portfolio of research projects that will conduct hybrid effectiveness-implementation trials to address key barriers to the delivery of evidence-based OUD treatments to justice-involved populations. The ultimate goal is to translate research into practice and improve the availability and accessibility of MOUD for this vulnerable population. The grant opportunity is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. However, non-domestic (non-U.S.) entities (foreign organizations) and non-domestic components of U.S. organizations are not eligible to apply. The closing date for this grant opportunity is January 22, 2025. The maximum award ceiling is $750,000. For more information and to apply, please visit the following link: [HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional)](http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-026.html). For any further inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics (U54 Clinical Trials Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics (U54 Clinical Trials Not Allowed)". This grant aims to address the lack of early translational funding and technical support for new product developers in the field of substance use disorder (SUD) pharmacotherapeutics. The grant seeks to establish a technical development center (or centers) that will provide researchers with the necessary support to move their ideas beyond the conceptual stage and into product development. This support includes assistance in target product profile development, clinical need assessment, project plan development, prototype development, proof-of-concept study design, preliminary safety assessments, and guidance on current and future regulatory requirements. The funding instrument for this grant is a Cooperative Agreement, and there is no cost sharing or matching requirement. The grant falls under the category of Health and is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments, non-domestic entities (foreign organizations), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territories or Possessions. The closing date for this grant opportunity is November 13, 2024. The maximum award ceiling is $1,900,000. For more information and to apply, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-056.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-056.html). For any inquiries, the contact email is grantsinfo@nih.gov.
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)". This grant falls under the category of Income Security and Social Services. The purpose of this grant is to support translational dissemination and implementation research focused on addressing overdose deaths and the intersection of pain and Opioid Use Disorder (OUD). The grant is expected to run for two years (FY23 and FY24) and has a maximum award ceiling of $750,000. Eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and Historically Black Colleges and Universities (HBCUs). Non-domestic (non-U.S.) entities and components are not eligible to apply. The deadline for applications is March 20, 2025. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-053.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-053.html).
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)". This funding opportunity aims to accelerate the development of medication for the treatment of Substance Use Disorders (SUDs) by supporting a diverse array of preclinical and/or clinical research projects. The goal is to fund medication studies that will have a high impact and quickly yield the necessary results to advance medications closer to FDA approval. The funding will be in the form of short-term (up to 3 years) and large (up to $5 million per year) cooperative agreements with close monitoring and significant scientific involvement of NIDA staff. This opportunity will enable critical medications development studies that would not be feasible using the traditional R01 activity code. Eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territory or Possession. The grant has a closing date of September 1, 2025, and an award ceiling of $5,000,000. For more information and to apply, visit the following link: [Grant Opportunity Details](https://grants.nih.gov/grants/guide/pa-files/PAR-22-202.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.